Telangana Super-Specialty Hospitals Corporation Limited
Founded: 2022
Status: Active
Designation: Director
DR
Dinakaran Bose Ronald Rose, Director and Nominee Director, with 30 companies.
Dinakaran Bose Ronald Rose has 5 years in corporate governance. Holds Director and Nominee Director roles. Currently with 11 companies, including Telangana Super-Specialty Hospitals Corporation Limited and Andhra Pradesh State Beverages Corporation Limited. Formerly with 19 companies, such as Andhra Pradesh Power Development Company Ltd and Andhra Pradesh Power Generation Corporation Limited. Engaged in General Business, Finance.
Founded: 2022
Status: Active
Designation: Director
Founded: 2015
Status: Active
Designation: Director
Founded: 2020
Status: Active
Designation: Nominee Director
Founded: 2020
Status: Active
Designation: Nominee Director
Founded: 2020
Status: Active
Designation: Nominee Director
Founded: 1973
Status: Active
Designation: Nominee Director
Founded: 2006
Status: Active
Designation: Nominee Director
Founded: 1998
Status: Active
Designation: Nominee Director
Founded: 1969
Status: Active
Designation: Nominee Director
Founded: 2019
Status: Active
Designation: Director
Founded: 1998
Status: Active
Designation: Director
Founded: 2000
Status: Active
Designation: Director
Explore Director's current and past company associations— Uncover their professional journey today!
Dinakaran Bose Ronald Rose has 5 years in corporate governance. Holds Director and Nominee Director roles. Currently with 11 companies, including Telangana Super-Specialty Hospitals Corporation Limited and Andhra Pradesh State Beverages Corporation Limited. Formerly with 19 companies, such as Andhra Pradesh Power Development Company Ltd and Andhra Pradesh Power Generation Corporation Limited. Engaged in General Business, Finance.
Dinakaran Bose Ronald Rose is associated with 11 companies as Director and Nominee Director.
Dinakaran Bose Ronald Rose has expertise in General Business, Finance.
Dinakaran Bose Ronald Rose has 5 years in corporate governance.